CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....